Published in Epilepsy Res on May 01, 1997
Long term outcome of temporal lobe epilepsy surgery: analyses of 140 consecutive patients. J Neurol Neurosurg Psychiatry (2002) 1.76
The evaluation of FDG-PET imaging for epileptogenic focus localization in patients with MRI positive and MRI negative temporal lobe epilepsy. Neuroradiology (2012) 0.82
A multiple testing procedure for clinical trials. Biometrics (1979) 26.80
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology (1999) 9.86
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology (1997) 8.50
The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03
Procedures for comparing samples with multiple endpoints. Biometrics (1984) 6.70
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology (2004) 5.86
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology (2005) 5.02
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology (2000) 4.89
MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology (1992) 4.87
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology (2002) 4.50
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect Immun (1981) 4.34
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
Trauma and multiple sclerosis: a population-based cohort study from Olmsted County, Minnesota. Neurology (1993) 4.04
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc (1991) 3.88
Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology (2000) 3.84
Designs for group sequential tests. Control Clin Trials (1984) 3.56
Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc (1971) 3.35
Verifying the stroke-free phenotype by structured telephone interview. Stroke (2000) 3.15
Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology (1989) 3.12
The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology (1999) 3.09
Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology (2007) 2.93
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology (2003) 2.88
Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve (1997) 2.86
Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology (1998) 2.77
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies. Infect Immun (1981) 2.76
Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol (1980) 2.75
Liver iron stores in patients with non-insulin-dependent diabetes mellitus. Mayo Clin Proc (1994) 2.71
Limitations of quantitative sensory testing when patients are biased toward a bad outcome. Neurology (1998) 2.70
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69
Memory and MRI-based hippocampal volumes in aging and AD. Neurology (2000) 2.65
Value of autonomic testing in reflex sympathetic dystrophy. Mayo Clin Proc (1995) 2.65
Long-term mortality after a first episode of status epilepticus. Neurology (2002) 2.60
Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol (1997) 2.60
Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology (1990) 2.56
Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA (2001) 2.53
Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg (1994) 2.50
Standard method for developing stroke registers in low-income and middle-income countries: experiences from a feasibility study of a stepwise approach to stroke surveillance (STEPS Stroke). Lancet Neurol (2007) 2.46
Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology (1995) 2.42
Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc (1981) 2.41
1H MR spectroscopy in common dementias. Neurology (2004) 2.39
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice. Infect Immun (1981) 2.39
Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN. Neurology (1998) 2.38
Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease. J Clin Epidemiol (1996) 2.27
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology (2000) 2.26
Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol (1994) 2.25
FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging (2001) 2.24
Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology (1997) 2.23
Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology (2008) 2.21
Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology (2001) 2.19
Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology (2003) 2.10
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: chemotactic responses of Vibrio cholerae and description of motile nonchemotactic mutants. Infect Immun (1981) 1.97
Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol (1991) 1.96
The value of thymectomy in myasthenia gravis: a computer-assisted matched study. Ann Surg (1976) 1.93
Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology (2001) 1.92
The appropriateness of analysis of variance and multiple-comparison procedures. Biometrics (1983) 1.89
Alpha-coma. Electroencephalographic, clinical, pathologic, and etiologic correlations. Arch Neurol (1975) 1.89
Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol (1991) 1.89
Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. Ann Neurol (1998) 1.86
Effect of chemotaxis on the interaction of cholera vibrios with intestinal mucosa. Am J Clin Nutr (1979) 1.85
Epidemiologic correlates of sporadic amyotrophic lateral sclerosis. Neurology (1991) 1.84
Cranial nerve palsy in spontaneous dissection of the extracranial internal carotid artery. Neurology (1996) 1.81
A complete comparative chromosome map for the dog, red fox, and human and its integration with canine genetic maps. Genomics (1999) 1.79
Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology (1995) 1.78
Assessment of body composition with use of dual-energy x-ray absorptiometry: evaluation and comparison with other methods. Mayo Clin Proc (1993) 1.77
Methods for measuring plasma hemoglobin in micromolar concentration compared. Clin Chem (1992) 1.77
Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol (1982) 1.77
Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care (1999) 1.74
Seizure outcome after anterior temporal lobectomy and its predictors in patients with apparent temporal lobe epilepsy and normal MRI. Epilepsia (2004) 1.73
Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology (1998) 1.72
MRI hippocampal volumes and memory function before and after temporal lobectomy. Neurology (1993) 1.68
A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (1994) 1.68
Cardiac troponin levels following monitored epileptic seizures. Neurology (2003) 1.64
Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology (1998) 1.64
Pregnancy in women with epilepsy : preliminary results of Kerala registry of epilepsy and pregnancy. Neurol India (2001) 1.61
Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project. Neurology (1993) 1.57
Mesial temporal sclerosis: diagnosis with fluid-attenuated inversion-recovery versus spin-echo MR imaging. Radiology (1996) 1.55
Pain in peripheral neuropathy related to rate and kind of fiber degeneration. Neurology (1976) 1.53
Population-based study of seizure disorders after cerebral infarction. Neurology (1996) 1.52
Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Am J Physiol (1993) 1.52
Correlation of continuous electroencephalograms with cerebral blood flow measurements during carotid endarterectomy. Stroke (1973) 1.52
Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol (1992) 1.49
Mechanism of stroke complicating cardiopulmonary bypass surgery. Aust N Z J Med (1994) 1.48
Resection of frontal encephalomalacias for intractable epilepsy: outcome and prognostic factors. Epilepsia (1997) 1.48
Theophylline effect on sleep in normal subjects. Chest (1993) 1.47
Idiopathic hypertrophic cranial pachymeningitis. Neurol India (2002) 1.46
Measurements of glucose control. Diabetes Care (1987) 1.45
Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J (1980) 1.44
Diagnostic interpretation of the intravenous tolbutamide test for insulinoma. Mayo Clin Proc (1989) 1.43
The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology (1991) 1.43